# US 2015/0104543 A1 · Organic acid production by fungal cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104543 A1
- Document ID: US20150104543A1
- Status: Published application
- Kind: A1
- Application number: 14/496,057
- Filed: 2014-09-25
- Published: 2015-04-16
- Earliest claimed: 2007-05-18
- Assignees: Dsm IP Assets B.V.
- Applicants: Dsm IP Assets B.V.
- Inventors: Aaron Adriaan WINKLER; Abraham Frederik DE HULSTER; Johannes Pieter VAN DIJKEN; Jacobus Thomas PRONK; Joshua TRUEHEART; Kevin T. MADDEN; Carlos Gancedo RODRIGUEZ; Carmen-Lisset Flores MAURIZ; Antonius Jeroen Adriaan VAN MARIS; Jacob C. HARRISON
- Web page: https://patentgrep.com/patent/US20150104543A1

## CPC

- C12N 15/52: Genes encoding for enzymes or proenzymes
- A23L 5/00: Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L 31/00: Edible extracts or preparations of fungi; Preparation or treatment thereof
- C07K 14/37: from fungi
- C12P 7/46: Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Improved systems for the biological production of organic acids are described.

## Claims

### Claim 1

A recombinant fungal cell having a genetic modification that decreases pyruvate decarboxylase (PDC) activity and a modification that increases or decreases fumarate reductase activity, wherein the recombinant fungal cell, when cultured under conditions that produce a C4 dicarboxylic acid, produces more of at least one C4 dicarboxylic acid than an otherwise identical fungal cell not having the genetic modification.

### Claim 2 (depends on 1)

The recombinant fungal cell of claim 1 having a genetic modification that increases malate dehydrogenase (MDH) activity.

### Claim 3 (depends on 1)

The recombinant fungal cell of claim 1 having modification selected from the group consisting of a modification that:
a. increases anaplerotic activity;
b. increases or decreases organic acid transport activity;
c. increases or decreases glucose sensing and regulatory polypeptide activity;
d. increases or decreases hexose transporter (HXT) activity; and
e. increases or decreases C4 dicarboxylic acid biosynthetic activity.

### Claim 4 (depends on 3)

The recombinant fungal cell of claim 3, wherein the modification to increase anaplerotic activity comprises at least one modification selected from the group consisting of a modification that:
f. increases pyruvate carboxylase (PYC) activity;
g. increases phosphoenolpyruvate carboxylase (PPC) activity;
h. increases or decreases phosphoenolpyruvate carboxykinase (PCK) activity;
i. increases or decreases pyruvate kinase (PYK) activity;
j. increases biotin protein ligase (BPL) activity;
k. increases biotin transport protein (VHT) activity;
l. increases or decreases bicarbonate transport activity;
m. increases carbonic anhydrase activity.

### Claim 5 (depends on 3)

The recombinant fungal cell claim 3, wherein the modification to increase or decrease C4 dicarboxylic acid biosynthetic activity comprises at least one modification selected from the group consisting of a modification that:
n. increases malate dehydrogenase (MDH) activity;
o. increases or decreases fumarase activity;
p. increases or decreases malate synthase activity;
q. increases or decreases malic enzyme activity;
r. increases or decreases isocitrate lyase activity;
s. increases or decreases ATP-citrate lyase activity;
t. increases or decreases succinate dehydrogenase activity.

### Claim 6 (depends on 1)

The recombinant fungal cell of claim 1, wherein the modification to decrease pyruvate decarboxylase (PDC) activity comprises at least one modification selected from the group consisting of a modification to decrease PDC1, PDC2, PDC5, or PDC6 activity.

### Claim 7 (depends on 1)

The recombinant fungal cell claim 1, wherein the modification to increase or decrease glucose sensing and regulatory polypeptide activity comprises at least one modification selected from the group consisting of modifications to increase or decrease SNF1, MIG1, MIG2, HXK2, RGT1, SNF3, RGT2, STD1, MTH1, GRR1, YCK1, HXK1, and GLK1 polypeptide activity

### Claim 8 (depends on 1)

The recombinant fungal cell of claim 1, wherein the genetic modification that increases or decreases glucose sensing and regulatory polypeptide activity does so by increasing or decreasing expression of a glucose sensing and regulatory polypeptide.

### Claim 9 (depends on 8)

The recombinant fungal cell of claim 8, wherein the genetic modification that increases expression is the addition of a gene encoding a glucose sensing and regulatory polypeptide.

### Claim 10 (depends on 8)

The recombinant fungal cell of claim 8, wherein the genetic modification that increases expression is a genetic modification that increases the transcription or translation of a gene encoding a glucose sensing and regulatory polypeptide.

### Claim 11 (depends on 8)

The recombinant fungal cell of claim 8, wherein the genetic modification that decreases expression is the deletion of all or part of a gene encoding a glucose sensing and regulatory polypeptide or the disruption of a gene encoding a glucose sensing and regulatory polypeptide.

### Claim 12 (depends on 3)

The recombinant fungal cell claim 3, wherein the modification to increase hexose transporter (HXT) activity comprises at least one modification selected from the group consisting of modifications to increase or decrease HXT1, HXT2, HXT3, HXT3, HXT4, HXT5, HXT6, or HXT7 polypeptide activity.

### Claim 13 (depends on 1)

The recombinant fungal cell of any of claim 1, wherein the fungal cell comprises more than one modification selected from the group consisting of modifications to:
v. increase anaplerotic activity;
w. decrease PDC activity;
x. increase or decrease organic acid transport activity;
y. increase or decrease glucose sensing and regulatory polypeptide activity;
z. increase hexose transporter (HXT) activity; and
aa. increase or decrease C4 dicarboxylic acid biosynthetic activity.

### Claim 14 (depends on 13)

The recombinant fungal cell of claim 13, wherein the more than one modifications are selected from the group consisting of modifications to:
bb. increase anaplerotic activity;
cc. decrease PDC activity;
dd. increase organic acid transport activity;
ee. increase glucose sensing and regulatory polypeptide activity; and
ee′ increase or decrease C4 dicarboxylic acid biosynthetic activity.

### Claim 15 (depends on 1)

The recombinant fungal cell of claim 1, wherein the fungal cell comprises more than two modifications selected from the group consisting of modifications to:
ff. increase anaplerotic activity;
gg. decrease PDC activity;
hh. increase or decrease organic acid transport activity;
ii. increase or decrease glucose sensing and regulatory polypeptide activity;
jj. increase HXT activity; and
kk. increase or decrease C4 dicarboxylic acid biosynthetic activity.

### Claim 16 (depends on 1)

A method of producing a C4-dicarboxylic acid, comprising: culturing a recombinant fungal cell of claim 1 under conditions that achieve C4-dicarboxylic acid production.

### Claim 17 (depends on 16)

The method of claim 16, further comprising a step of: isolating a produced C4-dicarboxylic acid.

### Claim 18 (depends on 17)

The method of claim 17, wherein the C4-dicarboxylic acid is selected from the group consisting of malic acid, fumaric acid, tartaric acid, and succinic acid.

### Claim 19 (depends on 16)

The method of claim 16, wherein the step of culturing under conditions that achieve C4-dicarboxylic acid production comprises culturing at a pH within the range of 1.5 to 7.

### Claim 20 (depends on 16)

The method of any claim 16, wherein the step of culturing under conditions that achieve C4-dicarboxylic acid production comprises culturing under conditions and for a time sufficient for C4-dicarboxylic acid to accumulate to a level within the range of 10 to 200 g/L.

### Claim 21 (depends on 1)

A method of preparing a food or feed additive containing a C4-dicarboxylic acid, the method comprising steps of:
ll. cultivating the recombinant fungal cell of claim 1 under conditions that allow production of the C4-dicarboxylic acid;
mm. isolating the C4-dicarboxylic acid; and
nn. combining the isolated C4-dicarboxylic acid with one or more other food or feed additive components.

### Claim 22 (depends on 21)

The method of claim 21, wherein the C4-dicarboxylic acid is selected from the group consisting of malic acid, fumaric acid, tartaric acid, and succinic acid.

### Claim 23 (depends on 1)

A method of preparing a polymer containing a C4-dicarboxylic acid, the method comprising steps of:
oo. cultivating the recombinant fungal cell of claim 1 under conditions that allow production of the C4-dicarboxylic acid;
pp. isolating the C4-dicarboxylic acid; and
qq. combining the isolated C4-dicarboxylic acid with one or more polymer components.

### Claim 24 (depends on 1)

A method of preparing a C4-dicarboxylic acid derivative, the method comprising steps of:
a) cultivating the recombinant fungal cell of claim 1 under conditions that allow production of a C4-dicarboxylic acid;
b) isolating the C4-dicarboxylic acid; and
c) converting the isolated C4-dicarboxylic acid into a C4-dicarboxylic acid derivative.

### Claim 25 (depends on 24)

The method of claim 24 wherein the C4-dicarboxylic acid is chosen from one or more of malic acid, fumaric acid, tartaric acid, and succinic acid.
